Jiangxi Sanxin MedtecLtd Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Zhiping Mao

Chief executive officer

CN¥724.6k

Total compensation

CEO salary percentage	n/a
CEO tenure	13.4yrs
CEO ownership	0.4%
Management average tenure	3.2yrs
Board average tenure	4.4yrs

Recent management updates

Recent updates

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Apr 23

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Apr 04

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Mar 29

CEO

Zhiping Mao (49 yo)

13.4yrs

Tenure

CN¥724,600

Compensation

Mr. Zhiping Mao is General Manager of Jiangxi Sanxin Medtec Co.,Ltd. since December 26, 2010 and served as its Deputy General Manager.

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Zhiping Mao	GM & Non-Independent Director	no data	CN¥724.60k	0.41% CN¥ 16.4m
Beiting Zou	Chief Financial Officer	3.2yrs	CN¥475.70k	0.072% CN¥ 2.9m
Zhenrong Le	Deputy GM & Non-Independent Director	no data	CN¥690.10k	0.23% CN¥ 9.2m
Lingli Leng	Deputy General Manager	2.2yrs	CN¥667.30k	0.032% CN¥ 1.3m
Ming Liu	VP, Board Secretary & Non-Independent Director	no data	CN¥682.50k	0.057% CN¥ 2.3m
Ling Peng	Deputy General Manager	8.4yrs	CN¥690.10k	0.064% CN¥ 2.6m
Ganying Wang	Deputy General Manager	3.2yrs	CN¥615.00k	0.10% CN¥ 4.2m

3.2yrs

Average Tenure

41yo

Average Age

Experienced Management: 300453's management team is considered experienced (3.2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Zhiping Mao	GM & Non-Independent Director	13.4yrs	CN¥724.60k	0.41% CN¥ 16.4m
Zhenrong Le	Deputy GM & Non-Independent Director	1.3yrs	CN¥690.10k	0.23% CN¥ 9.2m
Ming Liu	VP, Board Secretary & Non-Independent Director	4.4yrs	CN¥682.50k	0.057% CN¥ 2.3m
Fenglian Lei	Vice Chairman	13.4yrs	CN¥724.60k	5.23% CN¥ 209.3m
Guofeng Chen	Independent Director	1.1yrs	no data	no data
Yixing Peng	Non-Independent Chairman	13.4yrs	CN¥805.00k	29.95% CN¥ 1.2b
Zhenzhu Yu	Chairman of the Board of Supervisors	8.4yrs	no data	no data
Haihong Jiang	Independent Director	4.4yrs	CN¥76.50k	no data
Lin Zhang	Non-Employee Supervisor	7.4yrs	no data	0.062% CN¥ 2.5m
Meihua Zeng	Supervisor	3.8yrs	no data	no data
Xiaohua Xia	Independent Director	1.1yrs	no data	no data

4.4yrs

Average Tenure

48yo

Average Age

Experienced Board: 300453's board of directors are considered experienced (4.4 years average tenure).

Jiangxi Sanxin MedtecLtd Management

Management criteria checks 4/4

Key information

Recent management updates

Jiangxi Sanxin Medtec Co.,Ltd., Annual General Meeting, Apr 16, 2024

Insufficient new directors

High number of new directors

Recent updates

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Dividend of CN¥0.15 announced

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q1, 2024 Results on Apr 17, 2024

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Full year 2023 earnings released: EPS: CN¥0.40 (vs CN¥0.36 in FY 2022)

Jiangxi Sanxin Medtec Co.,Ltd., Annual General Meeting, Apr 16, 2024

Jiangxi Sanxin Medtec Co.,Ltd. (SZSE:300453) announces an Equity Buyback for CNY 60 million worth of its shares.

Investor sentiment deteriorates as stock falls 19%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.074 in 3Q 2022)

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2023 Results on Oct 21, 2023

Second quarter 2023 earnings released: EPS: CN¥0.087 (vs CN¥0.11 in 2Q 2022)

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2023 Results on Aug 05, 2023

First quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.093 in 1Q 2022)

Now 21% undervalued

Full year 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.40 in FY 2021)

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.096 (vs CN¥0.11 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.094 in 2Q 2021)

Jiangxi Sanxin Medtec Co.,Ltd. Announces Final Cash Dividend for 2021, Payable on 29 April 2022

High number of new directors

Jiangxi Sanxin Medtec Co.,Ltd. Announces Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.095 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.094 (vs CN¥0.076 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.05 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.24 in FY 2019)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.24 in FY 2019)

New 90-day high: CN¥18.61

Jiangxi Sanxin Medtec Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥15.92

Third quarter earnings released

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2020 Results on Oct 19, 2020

New 90-day low - CN¥17.05

Earnings released

New 90-day high - CN¥24.73

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2020 Results on Aug 19, 2020

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age